Characterization of Insufficient Responders to Ustekinumab in Patients With Moderate-to-Severe Psoriasis in the US Corrona Psoriasis Registry. Article

publication date

  • 2020

published in

keywords

  • Corrona Psoriasis Registry
  • Psoriasis
  • effectiveness
  • ustekinumab